Future Directions in Transfusion Practice

  • M. Girard
Part of the Developments in Hematology and Immunology book series (DIHI, volume 22)


What transfusion practice might be in a near future takes certainly an important place amongst the thoughts of everyone in our transfusion community. In that field I do not intend to play the role of the foreteller, but I shall rather give some personal impressions and feelings about what could affect our practice and how we should face it.


Blood Bank Transfusion Practice Mouse Bone Marrow Cell Hematoporphyrin Derivative Blood Salvage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Prodouz KN, Fratantoni JC, Boone EJ, Boone RF. Use of laser UV inactivation of virus in blood products. Blood 1987; 70: 589–592.PubMedGoogle Scholar
  2. 2.
    Oliphant JW, Hollaender A. Homologous serum jaundice: experimental inactivation of etiologic agent in serum by ultraviolet irradiation. Pub Health Rep 1946; 61: 598–602.CrossRefGoogle Scholar
  3. 3.
    Skiles H, Judy MM, Newman JT. Photodynamic inactivation of viruses with hematoporphyrin derivatives. Am Soc for Microbiol 1985; 7: A38.Google Scholar
  4. 4.
    Iscoff R. Dye lasers used to treat blood. Lasers and Optronics, March 1988.Google Scholar
  5. 5.
    Matthews JL, Newman JT, Sogandaresbernal Fet al. Photodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion 1988; 28: 81–83.PubMedCrossRefGoogle Scholar
  6. 6.
    CCBC Newsletter. July 1, 1988.Google Scholar
  7. 7.
    Sirchia G, Rebulla P, Parravicini A, Carnelli V, Gianotti GA, Bertolini F. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987; 27: 402–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normaly in A, B and O individuals. Science 1981; 215: 168–70.CrossRefGoogle Scholar
  9. 9.
    Kahn RA, Duffy BF, Rodey GE. Ultraviolet irradiation of platelets concentrates abrogates lymphocyte activation without affecting platelet function in vitro. Transfusion 1985; 25: 547–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Slichter SJ. Prevention of platelet alloimmunization. In: Murawski K, Peetom F (eds). Transfusion medicine: recent technological advances. New York: Alan R Liss Inc 1986: 83–116.Google Scholar
  11. 11.
    Autologous and directed blood programs technical workshop. American Ass of Blood Banks: Arlington, VA 1987.Google Scholar
  12. 12.
    Standards for Blood Banks and Transfusion Services. 12th edition. American Ass of Blood Banks: Arlington, VA 1987: 38–41.Google Scholar
  13. 13.
    Technical Manual. 9th edition. American Ass of Blood Banks: Arlington, VA 1985: 359–68.Google Scholar
  14. 14.
    Brzica SM, Pineda AA, Taswell HT. Autologous blood transfusion. CRC Crit Rev Clin Lab Sci 1979; I: 31–56.CrossRefGoogle Scholar
  15. 15.
    Baudelot J. Transfusion autologue. Meeting of the Société Nationale de Transfusion Sanguine, Fey 1988. Rapport du Groupe de Travail de la SNTS.Google Scholar
  16. 16.
    Klebanoff G. Early clinical experience with a disposable unit for the intraoperative salvage and reinfusion of blood loss (intraoperative autotransfusion). Am J Surg 1970; 120: 718–722PubMedCrossRefGoogle Scholar
  17. 17.
    Gilcher RO, Orr MD. Intraoperative autotransfusion. Transfusion 1975; 15: 520.Google Scholar
  18. 18.
    Wilson JD, Utz DC, Taswell HF. Autotransfusion during transurethral resection of the prostate: Technique and preliminary clinical evaluation. Mayo Clin Proc 1969; 44: 374–386.PubMedGoogle Scholar
  19. 19.
    Watson Williams EJ. Use of Haemonetics centrifuge to conserve blood during heart surgery. Proceedings of the Haemonetics Advanced Pheresis Seminar. Braintree, MA, 1974.Google Scholar
  20. 20.
    Schaff HV, Haver JM, Brawley RK. Autotransfusion in cardiac surgical patients after operation. Surgery 1978; 84: 713–8.PubMedGoogle Scholar
  21. 21.
    Cordell AIR, Lavender SW. An appraisal of blood salvage techniques in vascular and cardiac operations. Ann Thorac Surg 1981; 31: 421–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Keeling AM, Gray LA, Brink MA Hillerich VK, Bland KI. Intraoperative autotransfusion: experience in 725 consecutive cases. Ann Surg 1983; 197: 536–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Dzid WH, Jenkins R. Use of intraoperative blood salvage during orthotopic liver transplantation. Arch Surg 1985; 120: 946–8.CrossRefGoogle Scholar
  24. 24.
    Nelson CA, Motscham T, Rettik GS, Williamson KR, Krom R, Taswell HF. Early transfusion experience in a liver transplant program. Transfusion 1986; 26: 559.Google Scholar
  25. 25.
    Duncan SE, Klebanoff G, Rogers W. A clinical experience with intraoperative transfusion. Ann Surg 1974; 180: 296–304.PubMedCrossRefGoogle Scholar
  26. 26.
    Thurer RL, Haver JM. Autotransfusion and blood conservation. Curr Probl Surg 1982; 19: 100 /56.Google Scholar
  27. 27.
    Slovitar HA, Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967; 9: 191–3.Google Scholar
  28. 28.
    Slovitar HA, Yamada H, Ogashi S. Some effects of intravenous administered fluorochemicals in animals. Fed Proc 1970; 29: 1755–7.Google Scholar
  29. 29.
    Clark LC, Gollan P. Survival of mammals breathing organics liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152: 1755–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Mitsuno T, Okyanagi HN, Naitro R. Clinical studies of a perfluoro chemical whole blood substitute (Fluorol DA). Ann Surg 1982; 195: 60–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Kitazawa M, Ohnishi Y. Long term experiment of perfluorochemicals using rabbits. Virchows Arch A 1982; 398: 1–10.CrossRefGoogle Scholar
  32. 32.
    Mok W, Cuen DE, Mazur A. Crosslinked hemoglobins as potential protein expanders. Fed Proc 1975; 34: 1458–60.PubMedGoogle Scholar
  33. 33.
    De Venuto F, Zegna AI. Distinctive characteristics of pyridoxylated polymerized hemoglobin. In: Advances in blood substitute research. Alan R Liss Inc: New York 1983: 29–40.Google Scholar
  34. 34.
    Tye RW, Medina F, Bilin RB. Modification of hemoglobin–Tetrameric stabilization. In: Advances in blood substitute research. Alan R Liss Inc: New York 1983: 41–50.Google Scholar
  35. 35.
    Djordevich L, Miller IF. Synthetic erythrocyte from lipid encapsulated hemoglobin. Exp Hematol 1980; 8 (5): 584–92.Google Scholar
  36. 36.
    Hunt CA, Burnette RR, MacGregor RD. Synthesis and evaluation of a prototype artificial red cell. Science 1985; 230: 1165–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Chang TMS. Artificial cells. Charles Thomas: Springfield Ill 1972.Google Scholar
  38. 38.
    Till JE, MacCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Rad Res 1961; 14: 213–22.CrossRefGoogle Scholar
  39. 39.
    Bradley R, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287–300.PubMedCrossRefGoogle Scholar
  40. 40.
    Wright DG, Meagher RC, Salvado AJ. Human test tube bone marrow. In: Muranski K, Peetom F (eds). Transfusion medicine recent technological advances. Alan R Liss Inc: New York 1986: 135–57.Google Scholar
  41. 41.
    Jacobs K, Shoemaker G, Rudersdorf R et al. Isolation and characterization of genomic and DNA clones of human erythroprotein. Nature 1985; 313: 806–10.PubMedCrossRefGoogle Scholar
  42. 42.
    Rosenberg SA, Lotze MT, Mirull LM. Observation on the systematic administration of autologous lymphokine activated killer cells with metastatic cancer. N Engl J Med 1985; 313: 1485–92.PubMedCrossRefGoogle Scholar
  43. 43.
    Crawford MN, Gottman FE, Gottman CA. Microplate system for routine use in blood bank laboratories. Transfusion 1970; 10: 258.PubMedCrossRefGoogle Scholar
  44. 44.
    Reviron M, Reviron J. Application d’une microméthode d’agglutination au phénotypage erythrocytaire. Rev. Franc de Transf et Immuno-hematologie 1980; 23: 131–9.CrossRefGoogle Scholar
  45. 45.
    Technical manual. American Ass of Blood Banks: Arlington VA 1985:435–462.Google Scholar
  46. 46.
    Severns ML, Schoeppner SL, Cozart MJ, Friedman LI, Schanfield MS. Automated determination of ABO/Rh in microplates. Vox Sang 1984; 47: 293–303.PubMedCrossRefGoogle Scholar
  47. 47.
    Girard M. Automation in blood banking. Vox Sang 1986; 51 (Supp 1): 52–56.PubMedCrossRefGoogle Scholar
  48. 48.
    Friedman LI, Severns ML. Application of robotics in blood banking. Vox Sang 1986; 51 (Supp 1): 57–62.PubMedCrossRefGoogle Scholar
  49. 49.
    Rachel JM, Sinor LT, Beck ML, Plapp FV. A solid phase antiglobulin test. Transfusion 1985; 25: 24–26.PubMedCrossRefGoogle Scholar
  50. 50.
    Sinor LT, Rachel JM, Beck ML, Bayer WL, Coenen WN, Plapp FV. Solid phase ABO grouping and Rh typing. Transfusion 1985; 25: 21–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Rosenfield RE, Kochwa SE, Kaczera Z. Solid phase serology for the study of human erythrocyte antigen-antibody reactions. Proceedings Plenary session. Abstractbook, 25th Congress of ISBT. Paris 1978: 27.Google Scholar
  52. 52.
    Beck ML, Plapp FV, Sinor LT, Rachel JM. Solid phase techniques in blood transfusion serology. CRC Grit Rev Lab Sci 1986; 22: 317.CrossRefGoogle Scholar
  53. 53.
    Lapierre Y. French patent application 85–02010. Bopi 1986; 33: No 2 577–321.Google Scholar
  54. 54.
    Lapierre Y. The gelt test: a new approach for detection of red cell antibodies/antigens in a solid phase. Abstractbook, 20th Congress ISBT. London 1988: 145.Google Scholar
  55. 55.
    Tardivel R. Personnal communication.Google Scholar
  56. 56.
    Saleun JP, Bryckaert J, Deroff P. La carte à la Transfusion de A à Z. Rev Franç de Transf et Immuno-hématologie 1985; 28: 159–74.CrossRefGoogle Scholar
  57. 57.
    Commission Nationale de l’Informatique et des Libertés. Informatique et libertés. Journal officiel de la République Française 1980, No 1473.Google Scholar
  58. 58.
    Jolly D. In: L’“Hôpital du 21ème siècle”. XI:123–31. Economica Editor, Paris 1988.Google Scholar
  59. 59.
    Shifman MA, Vesilind GW. Treact: an expect system consultation program to aid in the diagnosis of transfusion reactions. Transfusion 1988; 28: 253–257.PubMedCrossRefGoogle Scholar
  60. 60.
    Coffin CM, Matz K, Rich E. Algorithms for evaluating appropriatness of blood transfusion. Transfusion 1987; 27: 562.Google Scholar
  61. 61.
    Borucki DT. Home blood transfusion: control by a community hospital. In: Home Transfusion Therapy, American Ass of Blood Banks: Arlington VA 1986.Google Scholar
  62. 62.
    Summary of the Third Meeting of the ISBT Working Party on automation and data processing. New York 1981. Vox Sang 1982; 42: 322–324.Google Scholar
  63. 63.
    Biotechnology in blood transfusion. Smit Sibinga CTh, Das PC, Overby LR (eds). Boston, Dordrecht, London: Kluwer Academic Publishers 1988.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • M. Girard

There are no affiliations available

Personalised recommendations